These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 37383403)

  • 1. Liquid biopsy for early detection and therapeutic monitoring of hepatocellular carcinoma.
    Choi EJ; Kim YJ
    J Liver Cancer; 2022 Sep; 22(2):103-114. PubMed ID: 37383403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Applications of Liquid Biopsy in Hepatocellular Carcinoma.
    Yang JC; Hu JJ; Li YX; Luo W; Liu JZ; Ye DW
    Front Oncol; 2022; 12():781820. PubMed ID: 35211399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of cell free DNA in the diagnosis of HCC.
    Banini BA; Sanyal AJ
    Hepatoma Res; 2019; 5():. PubMed ID: 31673629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current Status and Prospects of Liquid Biopsy for Hepatocellular Carcinoma].
    Kang J; Kim SS
    Korean J Gastroenterol; 2023 Jul; 82(1):1-9. PubMed ID: 37489076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma.
    Xu J; Zhao Y; Chen Z; Wei L
    J Pers Med; 2024 Apr; 14(4):. PubMed ID: 38673047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
    Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
    Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
    Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
    Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
    Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
    Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy derived circulating tumor cells and circulating tumor DNA as novel biomarkers in hepatocellular carcinoma.
    Temraz S; Nasr R; Mukherji D; Kreidieh F; Shamseddine A
    Expert Rev Mol Diagn; 2022 May; 22(5):507-518. PubMed ID: 35758097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy in Hepatocellular Carcinoma: Where Are We Now?
    Pelizzaro F; Cardin R; Penzo B; Pinto E; Vitale A; Cillo U; Russo FP; Farinati F
    Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34068786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid biopsy in CNS tumors: Current status & future perspectives.
    Husain N; Husain A; Mishra S; Srivastava P
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S111-S121. PubMed ID: 35562141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Ye Q; Ling S; Zheng S; Xu X
    Mol Cancer; 2019 Jul; 18(1):114. PubMed ID: 31269959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA.
    Li J; Han X; Yu X; Xu Z; Yang G; Liu B; Xiu P
    J Exp Clin Cancer Res; 2018 Sep; 37(1):213. PubMed ID: 30176913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Application of Liquid Biopsy Techniques in High-Risk Population for Hepatocellular Carcinoma.
    Ding J; Zhao W
    Cancer Manag Res; 2022; 14():2735-2748. PubMed ID: 36133739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of Circulating Tumor Cells and Their Implications as a Biomarker for Diagnosis, Prognostication, and Therapeutic Monitoring in Hepatocellular Carcinoma.
    Ahn JC; Teng PC; Chen PJ; Posadas E; Tseng HR; Lu SC; Yang JD
    Hepatology; 2021 Jan; 73(1):422-436. PubMed ID: 32017145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers for hepatocellular carcinoma based on body fluids and feces.
    Guan MC; Ouyang W; Wang MD; Liang L; Li N; Fu TT; Shen F; Lau WY; Xu QR; Huang DS; Zhu H; Yang T
    World J Gastrointest Oncol; 2021 May; 13(5):351-365. PubMed ID: 34040698
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.